CClinicalTrials.gg
CompletedNCT01260077Updated Dec 15, 2010

Steady State Vestibular Evoked Myogenic Potentials

An observational study in Normal Vestibular Evoked Potentials in Frequency Domain, sponsored by Universidade Estadual de Ciências da Saúde de Alagoas. Completed. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2010-12-15.

Sponsored by Universidade Estadual de Ciências da Saúde de Alagoas · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Objective: At present, vestibular evoked myogenic potentials are analyzed only in the time domain. A technique to evaluate this potential in the frequency domain could provide more information, but has only been applied within the last year. Design and Study Sample: In this study we recorded vestibular evoked myogenic potential in the time domain, in 156 ears of 78 normal-hearing young adults, at frequencies of 250, 500, 1000 and 2000 Hz, with intensity of 90 dB nHL. Next, the steady state vestibular evoked myogenic potential was recorded at the same carrying frequencies, modulated at 20, 37, 40, 43, 70, 77 and 80 Hz. Results: The responses found by modulated frequency, regardless of carrier, recorded a higher presence of peaks and mean amplitudes between 20 and 70 Hz, especially at 40 Hz. Conclusions: The results show that the observation technique in the frequency domain is feasible and shows a strong association with the time domain for recording vestibular evoked myogenic potentials, at carrying frequencies of 250, 500, 1000 or 2000 Hz.

02

Conditions studied

  • Normal Vestibular Evoked Potentials in Frequency Domain
03

In context

Lead sponsor

Universidade Estadual de Ciências da Saúde de Alagoas is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Normal subjects.

Eligibility criteria

Inclusion criteria: age between 18 and 35 years and auditory threshold less than or equal to 20 dBHL, between 0.5 and 8 kHz, with inter-ear frequency difference less than or equal to 10 dB.

Exclusion criteria were: exposure to occupational or leisure noise; otological surgery; more than three ear infections within the last year; use of ototoxic medication; buzzing in the ear, vertigo, dizziness or other cochlear-vestibular symptoms ; presence of systemic alterations that could contribute to cochlear-vestibular pathologies, such as diabetes, hypertension, dyslipidemias and/or hormonal alterations.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional

Groups and cohorts

  • Experimental group

    The sample was composed of 78 individuals (156 ears), 40 females (80 ears) and 38 males (76 ears).

06

What researchers measure

Primary outcomes

  1. A technique to evaluate vestibular evoked myogenic potential in the frequency domain

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • de Oliveira AC, Pereira LD, Colafemina JF, de Lemos Menezes P. Amplitude modulated vestibular evoked myogenic responses: a study of carrier and modulating frequencies. Acta Otolaryngol. 2014 Aug;134(8):796-801. doi: 10.3109/00016489.2014.909605. Epub 2014 Jun 9. PubMed 24909625 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01260077
Lead sponsor
Universidade Estadual de Ciências da Saúde de Alagoas
First posted
Dec 15, 2010
Last update
Dec 15, 2010

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion